α,β-unsaturated

Isophorone 是一种可用作聚合物前体的 α,β-不饱和环状酮。

trans-2-Undecenoic acid ((E)-Undec-2-enoic acid) 是一种 α,β-不饱和羧酸，其特征在于酸二聚体，相应的二聚体通过羧基 C=O···H-O 的分子间氢键连接。

(Z)-2-decenoic acid (cis-dec-2-enoic acid) 是一种由铜绿假单胞菌产生的不饱和脂肪酸。它能够诱导一系列革兰氏阴性细菌(包括铜绿假单胞菌)和革兰氏阳性细菌形成的生物膜发生分散反应。它能够抑制生物膜发育。

Levomenol ((-)-α-BISABOLOL) 是一种单环倍半萜醇，具有有神经保护、抗氧化、抗炎和抗凋亡的作用。它可减轻三叉神经性疼痛啮齿动物模型的伤害性行为和中枢敏感性。它通过减少小鼠永久性局灶性脑缺血诱导的促炎标志物，防止神经元损伤和记忆缺陷。

Linoleic acid (9,12-octadecadienoic acid) 是一种天然的多不饱和脂肪酸，存在于动植物油中。Linoleic acid 是一种必需脂肪酸，是膜磷脂的一部分。

Eicosapentaenoic Acid 是一种 ω-3 脂肪酸。

Pironetin binds to α-tubulin and is an effective inhibitor of microtubule polymerization. It also has cell cycle arrest and antitumor activity. Pironetin is an α β unsaturated lactone isolated from Streptomyces species.

7α,24(S)-Dihydroxycholesterol ((3β,7α,24S)-Cholest-5-ene-3,7,24-triol) 作为肝X受体 (LXR) 的配体，能特异性地与 LXRα 及 LXRβ 的配体结合域相结合。此化合物通过 E-α,β-烯酮的合成途径制备，使用砷叶立德和 J-叔丁基二甲基硅氧基-双正-5-胆烯醛作为起始反应物，经过多步反应转化最终得到 7α,24(S)-Dihydroxycholesterol。

GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor.

CAY10410 is an analog of prostaglandin D2/prostaglandin J2 (PGD2/PGJ2) with structural modifications intended to give it PPARγ ligand activity and resistance to metabolism. 15-deoxy-δ12,14-PGJ2 has been shown to be a potent ligand for PPARγ. Metabolism of the cyclopentenone prostaglandins PGA2, PGJ2, and δ12-PGJ2 occurs via glutathione addition across the α,β unsaturated enone. CAY10410 was designed as an analog of the PPARγ-binding prostaglandins which could not undergo this conjugation reaction. In human neuroblastoma SH-SY5Y cells, CAY10410 was not cytotoxic at up to 25 μM. It also failed to covalently modify thioredoxin or induce oxidative stress at 50 μM.

(-)-Cleistenolide是从Cleistochlamys kirkii Oliver中分离得到的一种α,β-不饱和δ-内酯，具有抗菌和抗肿瘤活性。

Trans-​2-​Hexenal (trans-2-Hexenal) 是α,β-不饱和羰基化合物，可保护植物免受有害物质的侵害。

Δ2-cisEicosenoic acid, an α,β-unsaturated fatty acid extracted and purified from fresh water clams, alongside its related compound 2-octadecenoic acid, which improves liver function and decreases blood sugar in streptozocin-induced diabetic rats, and its salts, holds potential medicinal value for treating diabetes and enhancing lipid metabolism.

Δ2-transEicosenoic acid, an α,β-unsaturated fatty acid, emerges as a by-product during the synthesis of Δ2-ciseicosenoic acid, which along with its salts, shows promise in diabetes treatment and lipid metabolism enhancement. Additionally, the compound 2-octadecenoic acid is recognized for its ability to enhance liver function and reduce blood sugar levels in streptozocin-induced diabetic rats.